Boston, Massachusetts, United States
Contact Info
2K followers
500+ connections
Boston, Massachusetts, United States
Contact Info
2K followers
500+ connections
About
Proven track record in both small biotech and large global pharmaceutical companies in…
Activity
-
It was wonderful to participate in Vertex's recent Outstanding Research Awards and Grootenhuis Discovery Award Event, where the organization comes…
It was wonderful to participate in Vertex's recent Outstanding Research Awards and Grootenhuis Discovery Award Event, where the organization comes…
Liked by E. Morrey Atkinson
-
Having worked in the CDMO industry for almost two decades, I have always had great respect for Lonza’s ability to transform and grow at pace. It is a…
Having worked in the CDMO industry for almost two decades, I have always had great respect for Lonza’s ability to transform and grow at pace. It is a…
Liked by E. Morrey Atkinson
-
We’re strengthening our leadership team and welcoming Pierre-Alain Ruffieux as our incoming Chief Operating Officer! Bringing more than 20 years of…
We’re strengthening our leadership team and welcoming Pierre-Alain Ruffieux as our incoming Chief Operating Officer! Bringing more than 20 years of…
Liked by E. Morrey Atkinson
Experience & Education
-
Vertex Pharmaceuticals
View E. Morrey’s full experience
See their title, tenure and more.
or
More activity by E. Morrey
-
Today marks the close of 89bio’s Q2 All Company Week, a cherished time when our team flies into the Company’s San Francisco office from all over the…
Today marks the close of 89bio’s Q2 All Company Week, a cherished time when our team flies into the Company’s San Francisco office from all over the…
Liked by E. Morrey Atkinson
-
Big thanks to OUTbio for hosting a lovely Tuesday evening of food, music and networking at the Vitamin Sea Beer Garden! #bioinformatics…
Big thanks to OUTbio for hosting a lovely Tuesday evening of food, music and networking at the Vitamin Sea Beer Garden! #bioinformatics…
Liked by E. Morrey Atkinson
-
As we enter the second half of 2024, we are more steadfast than ever in our commitment to delivering innovative therapies for liver disease patients.…
As we enter the second half of 2024, we are more steadfast than ever in our commitment to delivering innovative therapies for liver disease patients.…
Liked by E. Morrey Atkinson
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More